FI951468A - Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö - Google Patents

Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö Download PDF

Info

Publication number
FI951468A
FI951468A FI951468A FI951468A FI951468A FI 951468 A FI951468 A FI 951468A FI 951468 A FI951468 A FI 951468A FI 951468 A FI951468 A FI 951468A FI 951468 A FI951468 A FI 951468A
Authority
FI
Finland
Prior art keywords
lipopeptide derivatives
preparation
lipopeptide
derivatives
bacterial infections
Prior art date
Application number
FI951468A
Other languages
English (en)
Swedish (sv)
Other versions
FI951468A0 (fi
Inventor
Rudolf Lattrell
Theodor Wollmann
Holger Wallmeier
Peter Hammann
Dieter Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI951468A0 publication Critical patent/FI951468A0/fi
Publication of FI951468A publication Critical patent/FI951468A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI951468A 1994-03-30 1995-03-28 Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö FI951468A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number Publication Date
FI951468A0 FI951468A0 (fi) 1995-03-28
FI951468A true FI951468A (fi) 1995-10-01

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951468A FI951468A (fi) 1994-03-30 1995-03-28 Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö

Country Status (25)

Country Link
US (1) US5629288A (fi)
EP (1) EP0688789B1 (fi)
JP (1) JP3653119B2 (fi)
KR (1) KR100360129B1 (fi)
CN (1) CN1111640A (fi)
AT (1) ATE219499T1 (fi)
AU (1) AU696566B2 (fi)
CA (1) CA2145826C (fi)
CZ (1) CZ287158B6 (fi)
DE (2) DE4411025A1 (fi)
DK (1) DK0688789T3 (fi)
ES (1) ES2178657T3 (fi)
FI (1) FI951468A (fi)
HK (1) HK1012017A1 (fi)
HU (1) HU218286B (fi)
IL (1) IL113160A (fi)
MA (1) MA23490A1 (fi)
NO (1) NO951198L (fi)
NZ (1) NZ270828A (fi)
OA (1) OA10142A (fi)
PL (1) PL180274B1 (fi)
PT (1) PT688789E (fi)
RU (1) RU2141970C1 (fi)
TW (1) TW336939B (fi)
ZA (1) ZA952555B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
WO1999020651A1 (fr) * 1997-10-21 1999-04-29 Sankyo Company, Limited Nouveaux composes antifongiques
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
WO2000063239A1 (fr) * 1999-04-16 2000-10-26 Sankyo Company, Limited Nouveaux composes antifongiques
MXPA02006028A (es) * 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos como agentes antibacterianos.
EP2295444A3 (en) 1999-12-15 2011-03-23 Cubist Pharmaceutical Inc. Lipopeptides as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
WO2002005837A1 (en) * 2000-07-17 2002-01-24 Intrabiotics Pharmaceuticals, Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
KR20080036661A (ko) 2000-12-18 2008-04-28 큐비스트 파마슈티컬즈 인코포레이티드 정제된 리포펩티드의 제조 방법
DE60232158D1 (de) 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
AU2003202878B2 (en) * 2002-01-03 2008-07-31 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
EP1656390A2 (en) * 2003-07-17 2006-05-17 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7888940B2 (en) * 2007-02-19 2011-02-15 Schlumberger Technology Corporation Induction resistivity cover
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
EP2674437A1 (en) * 2008-12-22 2013-12-18 Cubist Pharmaceuticals, Inc. Novel antibacterial agents for the treatment of GRAM positive infections
FI2504353T4 (fi) 2009-11-23 2023-11-30 Cubist Pharmaceuticals Llc Lipopeptidikoostumukset ja vastaavat menetelmät
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
PL180274B1 (pl) 2001-01-31
HU218286B (en) 2000-07-28
HK1012017A1 (en) 1999-07-23
ZA952555B (en) 1995-12-21
KR950032636A (ko) 1995-12-22
DK0688789T3 (da) 2002-10-14
CA2145826C (en) 2008-01-08
RU2141970C1 (ru) 1999-11-27
DE59510246D1 (de) 2002-07-25
JP3653119B2 (ja) 2005-05-25
NO951198D0 (no) 1995-03-29
AU1611095A (en) 1995-10-12
CA2145826A1 (en) 1995-10-01
EP0688789A1 (de) 1995-12-27
PL307914A1 (en) 1995-10-02
DE4411025A1 (de) 1995-10-05
MA23490A1 (fr) 1995-10-01
EP0688789B1 (de) 2002-06-19
US5629288A (en) 1997-05-13
NO951198L (no) 1995-10-02
IL113160A0 (en) 1995-06-29
IL113160A (en) 1999-04-11
HUT71584A (en) 1995-12-28
RU95106362A (ru) 1996-12-27
JPH07278186A (ja) 1995-10-24
ES2178657T3 (es) 2003-01-01
KR100360129B1 (ko) 2003-03-26
OA10142A (fr) 1996-12-18
PT688789E (pt) 2002-11-29
CN1111640A (zh) 1995-11-15
CZ287158B6 (en) 2000-10-11
CZ77995A3 (en) 1995-10-18
ATE219499T1 (de) 2002-07-15
NZ270828A (en) 1996-10-28
TW336939B (en) 1998-07-21
AU696566B2 (en) 1998-09-10
FI951468A0 (fi) 1995-03-28

Similar Documents

Publication Publication Date Title
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG101118A (en) Therapeutical compounds
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
BG103947A (en) Derivatives of 9-oxymerythromycin
AU555444B2 (en) Cephalosporin derivatives
NO971625L (no) Nye peptider med immunomodulatoriske effekter
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
DK0402806T3 (da) Krystallinske cephem-syreadditionssalte og fremgangsmåde til fremstilling heraf
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
PT874863E (pt) Derivados 3-desoxi-3-descladinose de eritromicinasa e b
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.

Legal Events

Date Code Title Description
MA Patent expired